D. Arnold describes different treatment scenarios available for patients with colorectal cancer (CRC) and liver metastases and subsequently focuses on selective internal radiotherapy (SIRT), in particular SIR-Spheres Y-90 resin microspheres. Furthermore, he elaborates the results from the SIRFLOX trial in first-line treatment of non-resectable CRC liver metastases.

Oncology Meeting Resources

Major Sponsors

AstraZeneca Janssen Lilly Oncology

Main Sponsors

Amgen Astellas Bayer Healthcare Boehringer Ingelheim Daiichi Sankyo Genomic Health Inc. Roche